31376499|t|Trans-cinnamaldehyde improves neuroinflammation-mediated NMDA receptor dysfunction and memory deficits through blocking NF-kappaB pathway in presenilin1/2 conditional double knockout mice.
31376499|a|A chronic neuroinflammatory response has been considered as a critical pathogenesis promoting neurodegenerative progression in Alzheimer's disease (AD). During neuroinflammatory process, microglia are excessively activated and simultaneously release numerous pro-inflammatory mediators that cause synaptic dysfunction in the forebrain prior to neuronal degeneration and memory deficits in AD. Thus, prevention of neuroinflammation-mediated synaptic dysfunction may be a potential therapeutic approach against neurodegenerative disorders. Trans-cinnamaldehyde (TCA) is a primary bioactive component derived from the stem bark of Cinnamomum cassia, and it possesses potent anti-inflammatory and neuroprotective activities in in vivo and in vitro experiments. However, the in-depth molecular mechanisms of TCA underlying anti-neuroinflammatory and neuroprotective effects on memory deficits in AD are still unclear. The presenilin 1 and 2 conditional double knockout (PS cDKO) mice exhibit AD-like phenotypes including obvious neuroinflammatory responses and synaptic dysfunction and memory deficits. Here, PS cDKO were used to evaluate the potential neuroprotective effects of TCA against neuroinflammation-mediated dementia by performing behavioral tests, electrophysiological recordings and molecular biology analyses. We observed that TCA treatment reversed abnormal expression of synaptic proteins and tau hyperphosphorylation in the hippocampus and prefrontal cortex of PS cDKO mice. TCA treatment also ameliorated NMDA receptor (NMDAR) dysfunction including impaired NMDAR-mediated responses and long-term potentiation (LTP) induction in the hippocampus of PS cDKO mice. Moreover, TCA possesses an ability to suppress neuroinflammatory responses by diminishing microglial activation and levels of pro-inflammatory mediators in the hippocampus and prefrontal cortex of PS cDKO mice. Importantly, improving NMDAR dysfunction and memory deficits of PS cDKO mice was due to the inhibition of neuroinflammatory responses through TCA's interruptive effect on the nuclear factor kappa B (NF-kappaB) signaling pathway. Therefore, TCA may be a potential anti-neuroinflammatory agent for deterring neurodegenerative progression of AD.
31376499	0	20	Trans-cinnamaldehyde	Chemical	MESH:C012843
31376499	30	47	neuroinflammation	Disease	MESH:D000090862
31376499	87	102	memory deficits	Disease	MESH:D008569
31376499	120	129	NF-kappaB	Gene	18033
31376499	141	154	presenilin1/2	Gene	19164;19165
31376499	183	187	mice	Species	10090
31376499	199	216	neuroinflammatory	Disease	MESH:D000090862
31376499	316	335	Alzheimer's disease	Disease	MESH:D000544
31376499	337	339	AD	Disease	MESH:D000544
31376499	349	366	neuroinflammatory	Disease	MESH:D000090862
31376499	452	464	inflammatory	Disease	MESH:D007249
31376499	486	506	synaptic dysfunction	Disease	MESH:C536122
31376499	533	554	neuronal degeneration	Disease	MESH:D009410
31376499	559	574	memory deficits	Disease	MESH:D008569
31376499	578	580	AD	Disease	MESH:D000544
31376499	602	619	neuroinflammation	Disease	MESH:D000090862
31376499	629	649	synaptic dysfunction	Disease	MESH:C536122
31376499	698	725	neurodegenerative disorders	Disease	MESH:D019636
31376499	727	747	Trans-cinnamaldehyde	Chemical	MESH:C012843
31376499	749	752	TCA	Chemical	MESH:C012843
31376499	817	834	Cinnamomum cassia	Species	119260
31376499	865	877	inflammatory	Disease	MESH:D007249
31376499	992	995	TCA	Chemical	MESH:C012843
31376499	1012	1029	neuroinflammatory	Disease	MESH:D000090862
31376499	1061	1076	memory deficits	Disease	MESH:D008569
31376499	1080	1082	AD	Disease	MESH:D000544
31376499	1106	1124	presenilin 1 and 2	Gene	19164;19165
31376499	1163	1167	mice	Species	10090
31376499	1176	1178	AD	Disease	MESH:D000544
31376499	1213	1230	neuroinflammatory	Disease	MESH:D000090862
31376499	1245	1265	synaptic dysfunction	Disease	MESH:C536122
31376499	1270	1285	memory deficits	Disease	MESH:D008569
31376499	1364	1367	TCA	Chemical	MESH:C012843
31376499	1376	1393	neuroinflammation	Disease	MESH:D000090862
31376499	1403	1411	dementia	Disease	MESH:D003704
31376499	1525	1528	TCA	Chemical	MESH:C012843
31376499	1670	1674	mice	Species	10090
31376499	1676	1679	TCA	Chemical	MESH:C012843
31376499	1858	1862	mice	Species	10090
31376499	1874	1877	TCA	Chemical	MESH:C012843
31376499	1911	1928	neuroinflammatory	Disease	MESH:D000090862
31376499	1994	2006	inflammatory	Disease	MESH:D007249
31376499	2069	2073	mice	Species	10090
31376499	2098	2115	NMDAR dysfunction	Disease	MESH:D060426
31376499	2120	2135	memory deficits	Disease	MESH:D008569
31376499	2147	2151	mice	Species	10090
31376499	2181	2198	neuroinflammatory	Disease	MESH:D000090862
31376499	2217	2220	TCA	Chemical	MESH:C012843
31376499	2250	2272	nuclear factor kappa B	Gene	18033
31376499	2274	2283	NF-kappaB	Gene	18033
31376499	2315	2318	TCA	Chemical	MESH:C012843
31376499	2343	2360	neuroinflammatory	Disease	MESH:D000090862
31376499	2414	2416	AD	Disease	MESH:D000544
31376499	Association	MESH:C536122	19165
31376499	Negative_Correlation	MESH:C012843	MESH:D000090862
31376499	Association	MESH:D060426	18033
31376499	Association	MESH:D008569	19164
31376499	Association	MESH:D008569	19165
31376499	Positive_Correlation	MESH:C012843	MESH:D008569
31376499	Negative_Correlation	MESH:C012843	MESH:D007249
31376499	Negative_Correlation	MESH:C012843	MESH:D003704
31376499	Positive_Correlation	MESH:C012843	MESH:D060426
31376499	Association	MESH:D000090862	19164
31376499	Association	MESH:D000090862	18033
31376499	Association	MESH:C536122	19164
31376499	Association	MESH:D000090862	19165
31376499	Association	MESH:D000544	19165
31376499	Association	MESH:D008569	18033
31376499	Negative_Correlation	MESH:C012843	18033
31376499	Association	MESH:D000544	19164

